Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Farrell

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Journal of Gastroenterology and Hepatology|February 27, 2003
Expanding horizons for the Journal: The role of the Journal of Gastroenterology and Hepatology FoundationGeoffrey C Farrell
Journal of Gastroenterology and Hepatology|November 22, 2012
JGH and me: a long and winding road-reflections of an outgoing Editor-in-ChiefGeoffrey C Farrell
Journal of Gastroenterology and Hepatology|February 22, 2008
A feast of new offerings from JGH in the year of the rat!Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|April 10, 2008
Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressingGeoffrey C Farrell
Journal of Gastroenterology and Hepatology|April 21, 2007
TNF-alpha as therapeutic target in NASH: tried, but not yet provenShivakumar Chitturi, Geoffrey C Farrell
Hepatology (Baltimore, Md.)|January 22, 2011
Identifying who is at risk of drug-induced liver injury: is human leukocyte antigen specificity the key?Shivakumar Chitturi, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|July 5, 2007
Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic healthShivakumar Chitturi, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|March 6, 2008
Hepatotoxic slimming aids and other herbal hepatotoxinsShivakumar Chitturi, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|May 25, 2012
Lessons from Lumiracoxib: are cyclooxygenase-2 inhibitors less hepatotoxic than non-selective non-steroidal anti-inflammatory drugs?Shivakumar Chitturi, Geoffrey C Farrell
Seminars in Liver Disease|June 18, 2002
Drugs and the liver updated, 2002Geoffrey C Farrell, Christopher Liddle
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Journal of Gastroenterology and Hepatology|February 27, 2003
Expanding horizons for the Journal: The role of the Journal of Gastroenterology and Hepatology FoundationGeoffrey C Farrell
Journal of Gastroenterology and Hepatology|November 22, 2012
JGH and me: a long and winding road-reflections of an outgoing Editor-in-ChiefGeoffrey C Farrell
Journal of Gastroenterology and Hepatology|February 22, 2008
A feast of new offerings from JGH in the year of the rat!Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|April 10, 2008
Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressingGeoffrey C Farrell
Journal of Gastroenterology and Hepatology|April 21, 2007
TNF-alpha as therapeutic target in NASH: tried, but not yet provenShivakumar Chitturi, Geoffrey C Farrell
Hepatology (Baltimore, Md.)|January 22, 2011
Identifying who is at risk of drug-induced liver injury: is human leukocyte antigen specificity the key?Shivakumar Chitturi, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|July 5, 2007
Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic healthShivakumar Chitturi, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|March 6, 2008
Hepatotoxic slimming aids and other herbal hepatotoxinsShivakumar Chitturi, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology|May 25, 2012
Lessons from Lumiracoxib: are cyclooxygenase-2 inhibitors less hepatotoxic than non-selective non-steroidal anti-inflammatory drugs?Shivakumar Chitturi, Geoffrey C Farrell
Seminars in Liver Disease|June 18, 2002
Drugs and the liver updated, 2002Geoffrey C Farrell, Christopher Liddle
Pageof 13